Lask, GP, Lowe, NG (eds). Lasers in Cutaneous and Cosmetic Surgery, 1st edn, London: Churchill Livingstone, vol. 15, pp. 119 – 23.
Akasaka,Y, Ishikawa,Y, Ono,I, Fujita,K, Masuda,T, Asuwa,N, Inuzuka,K, Kiguchi,H, Ishii,T, 2000. Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblas in vitro. Lab Invest; 80, pp. 345-57.
Akasaka,Y, Fujita,K, Ishikawa,Y, Asuwa,N, InuzukaK, Ishihara,M, Ito,M, Masuda,T, Akishima,Y, Zhang,L, Ishi,T, 2001. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen; 9 : pp. 501-6.
Albani,JR, 2007. Absorption spectroscopy theory. Principles and application of fluorescence spectroscopy. Blackwell Publishing; Oxford. pp. 1-11.
Alster,TS, 1997. Laser Treatment of Scars and Striae. In: Alster, TS (eds). Manual of Cutaneous Laser Techniques, 1st edn, Philadelphia New York: Lippincott – Raven, vol. 6, pp. 82 – 6.
Alster,TS, 1999. Laser Scar Revision. in: Alster, TS, Apfelberg, DB (eds).
Cosmetic Laser Surgery, 2nd edn. New York: Wiley-Liss, vol. 15, pp. 227 – 44.
Alster,TS, 2000. Laser Techniques for Scar Revision. in: Fitzpatrick, RE, Goldman, MP (eds). Cosmetic Laser Surgery, 1st edn. London: Mosby Inc, vol. 10, pp. 170 – 75.
Annes,J, Munger,J & Rifkin,D, 2003. Making sense of latent TGF-β activation. J cell Sci; 116: pp.217-24
Anigbogu,AN & Maibach,HI, 2000. Topical Corticosteroid Theraphy. in: Millikan, LE (eds). Drug Theraphy in Dermatology, 1st edn. New York: Marcel Dekker , vol. 1, pp. 57 – 78.
Armour,A, Scott,PG & Tredget,EE, 2007. cellular and molecular pathology of hypertrophic scar : basis for treatment. Treatment wound rep. reg, 15.S6-S17@2007 by the wound healing society.
Ketentuan pokok pengelompokan dan penandaan obat bahan alam Indonesia.
Berman,B & Flores,F, The Treatment of Hypertrophic scars and Keloids. EJ Dermatol, viewed 10 Januari 2010.
<http://bberman@mednet.med.miami.edu> Vol. 8.
Bock,O, Yu,H, Zitron,S, Bayat,A, Ferguson,MWJ, Mrowietz,U, 2005.
Studies of transforming growth factors β 1-3 and their receptors I and II in fibroblas of keloid and hypertrophic scars. Acta Dermato-Venereol; 85: pp. 216-20.
Bock,O, Ott,GS, Malewski,P, Mrowietz,U, 2006. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res; 297: pp. 433-38.
Burton,JL & Lovell,CR, 1998. Disorder of Connective Tissue. in: Champion, RH, Burton, JL, Burns, DA, Breathnach, SM (eds). Texbook of Dermatology, 6th edn. Malden MA: Blackwell Science, vol. 3, no. 44, pp. 2056 – 57.
Chang,YC, Huang,HP, Hsu,JD, Yang,SF, Wang,CJ, 2005. Hibiscus anthocyanins rich extract -induced apoptotic cell death in human promyelocytic leukemia cell. Toxicology and Applied Pharmacology. Elsevier, 205; pp.201-12.
Chen,M & Davidson,T, 2005. Scar management: prevetion and treatment strategies. Curr Op Otolaryngol Head Neck Surg; 13: pp. 242-7.
Chike-Obi,CJ, Cole,PD & Brissett..AE, 2009. Keloid : Pathogenesis, Clinical Features, and Management. Seminars In Plastic Surgery, vol 23, no. 3, pp. 178-83.
Crowther JR, 2002. Methods in molecular biology, the ELISA guidebook. The International Atomic Agency, Vienna, Austria; vol. 149. pp 1- 45 .
Dawber,R, Colver,G & Jackson,A, 1992. Equipment and techniques. in: Dawber,R, Colver,G, Jackson,A (eds). Cutaneous Cyrosurgery, 1st edn, London: Martin Dunitz, vol. 3, pp. 17 – 27.
Dean,RJ, 1998. in: Extraction methods for environmental analysis. University of Northhumbria at Newcastle, pp. 23 – 42.
Departemen Kesehatan RI, Direktorat Jenderal POM 1989. Materia Medika Indonesia, Jakarta.
Departemen Kesehatan RI 2007. Surat Keputusan Menteri Kesehatan no: 381/MENKES/SK/III/ 2007 tentang Kebijakan obat tradisional
nasional.
Departement of Phanerogamic Botany Swedish Museum and Natural History, 2002. Taksonomy Rosela viewed 25 April 2009 <Http/www:fufoe.yolasite.com/artikel/rosela>.
Desmouliere,A, Chaponnier,C & Gabbiani,G, 2005. Tissue repair, contraction and the myofibroblas. Wound Repair Regen; 13: pp. 7-12.
Dover,JS, Arndt,KA, Geronemus,RG, Alora, MD, 2000. Continuous and Pulsed Carbon Dioxide Laser Surgery. in: Dover, JS, Arndt, KA, Geronemus, RG, Alora, MB (eds). Illustrated Cutaneous and Aesthetic Laser Surgery, 2nd edn, Stamford CT: Appleton & Lange, vol.2, pp. 31 – 4.
Dufresne,RG, 1998. Surgical Complication: Prevention, Recognition, and Treatment. in: Ratz, JL, Geronemus, RG, Goldman, MP, Maloney, ME, Padilla, RS (eds). Text Book of Dermatologic Surgery, 1st edn, Philadelphia, NY: Lippincott-Raven Publ, vol. 13, pp. 66 – 7.
Dyakov,R, Petrova,M, Tzolova,N, Argirova,M, Hadjiiski,O, 2002. Treatment of Superficial Burns, Post Burns Scars, and Keloids with Contratubex® Gel: Annals of Burns and Fire Disasters, viewed june 2002.
<http://www.medbc.com/annals/review/vol.15/num.2/text/vol.15n2p0 .asp> vol. XV, no. 2.
Eishi,K, et al, 2003. Silicone gel sheets relieve pain and pruritis with clinical improvement of keloid: possible target of mast cells. J Dematol Treatment; 14: pp. 248-52
Evita,M, 2009. Antibacterial potency of Methanolic Extract of Roselle (Hibiscus sabdariffa L) Calyx Cultivated in Indonesia Against Staphylococcus aureus and Escherichia coli in vitro. The Journal of Medical School University of Sumatera Utara. vol. 42, no.4.pp.258-63
Federe WT, 1955. Experimental design: Theory and application, citation: Hanafiah KA (eds). Rancangan percobaan – Teori dan Aplikasi, 3th edn. Jakarta. Raja Grafindo Persada 2005, pp. 9-10.
Finnson,KW, Tam,BYY, Liu,K, Marcoux, A, Lepage, P, Roy, S, Bizet, AA, Phillp, A, 2006. Identification of CD109 as part of the TGF-β receptor system in human keratinocytes. FASEB; 20: pp. 1525-7.
From,L & Assad,D, 1999. Neoplasma, Pseudomonas, and Hyperlasias of the Dermis. in: Freedberg,IM, et al (eds). Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, vol. 1, pp. 1163 – 5.
Funayama,E, Chodon,T, Oyama,A, Sugihara,T, 2003. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblast : an important role in the pathogenesis of keloid. J Invest Dermatol. 121.pp.1326-31
Gauglitz,GG, Korting,HC, Pavicic,T, Ruzicka,T, Jeschke,MG, 2011. Hypertropic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Mol Med 17 (1-2) pp. 113-25.
Guix,B, Henriquez,I, Andreas,A, Finestres,F, Tello,JL, Martines,A 2001. Treatment of Keloids by High-Dose-Rate Brachytherapy: a Seven-Year Study. Int. J. Radiation Oncology Biol. Phys. <http://www.elsevier.science.com>, vol. 50, no. 1, pp. 167 – 72.
Gyuman,P, Yoon,BS, Moon,JH, Kim,B, Jun,EK, Oh,S, Kim,H, Song,HJ, Noh,JY, Oh,CH, You,S, 2008. Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling Pathway. Journal Investigative Dermatology. 128.pp.2429-41.
Harting,M, Hicks,M.J & Levy,ML, 2008. Dermal Hypertrophies, in: Wollf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ (eds).
Fitzpatrick’s Dermatology in General Medicine, 7th edn, New York: McGraw-Hill, vol. 1, pp. 553-4.
Harbone,JB, Mabry,TJ & Mabry,H, 1997. The flavonoids, Chapman and Hall London,.
Harbone,JB, 1987. Metode Fitokimia. Penuntun cara modern menganalisis tumbuhan, Penerjemah: Kosasih PW, Iwang,I, terbitan kedua, penerbit ITB Bandung.
Connective Tissue Growth Factor Signals. J. Agric. Food Chem. 57, 3073-79.
Kelly,AP, 1991. Keloids and Hypertrophic Scars. in: Parish, LC, Lask, GP (eds). Aesthetic Dermatology, 1st edn. New York, McGraw-Hill, vol. 8, pp. 58 – 64.
Kirton,M, 1999. Keloids and Hypertrophic scars, viewed October 1999. Grand Rounds, <http://omfs’s.com>.
Koc,E, Arca,E, Surucu,B, Kurumlu,Z, 2008. An Open, Randomized, Controlled, Comparative Study of the Combined Effect of Intralesional Triamcinolone Acetonide and Onion Extract Gel and Intralesional Triamcinolone Acetonide Alone in the Treatment of Hypertropic Scars and keloids. Dermatol Surg 34: pp.1507-14
Kokoska,MS, 2001. Hypertrophic Scarring and Keloids, <http//www.medicine.com>, pp. 1–7.
Lee, T, et al, 1999. Expression of transforming growth factor β 1,2 and 3 proteins in keloids. Ann Plast Surg; 43: pp. 179-84.
Lila,MA, 2004. Anthocyanins and Human Health: An In Vitro Investigative Approach. J Biomed Biotechnol. (5); pp.306-13.
Manuskiatti, Woraphong & Fitzpatrick, Richard E 2000. Treatment of Hypertrophic Scars and Keloids: A Multi-faceted Approach. Thaicosderm.org:
<http://www.thaicosderm.org/webmaster@thaicosderm.org>.
Markham,KR, 1988. Cara Mengidentifikasi Flavonoid.Penerjemah: Kosasih PW, Penerbit ITB Bandung.
Maryani,H & Kristiana,L, 2008. Khasiat & Manfaat Rosela, Cetakan kedua revisi. Tangerang: PT. Agromedia Pustaka, pp. 1-31.
Massage,J, 1996. TGF-β signaling: receptors, transducers, and Smad proteins. Cell; 85: pp.947.
McCormick,L, et al, 1999. Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol; 163:pp. 5693-9.
Nedelec,B, Shankowsky,H, Scott,PG, Ghahary,A & Tredget,EE, 2001. Myofibroblas and apotosis in human hypertrophic scars: the effects of interferon-alpha-2b. Surgery ; 130: pp. 798-808.
Olaitan,PB, 2009. Keloids: Assessment of effects and psychosocial-impacts on subjects in a black African population. Indian J Dermatol Venereol Leprol. 75:pp.368-72
Phan,T, et al, 2004. Spression of transforming growth factor-β/Smad signaling in keloid-darived fibroblas by quercetin: implications for the treatment of excessive scars. J Trauma Inj Inf Crit Care ; 57: pp. 1032-7.
Pramono,LA, 2010. Pengobatan herbal: Menuju era fitofarmaka nasional yang berdaya saing internasional. Medicinus vol. 22, no. 4. ed Desember 2009 – Februari 2010, pp. 160-2.
Prior,RL & Wu,X, 2006. Anthocyanins : Structural characteristics that result in unique metabolic patterns and biological activities. Free Radical Research, 40(10): pp.1014-28.
Raney,RW, 1993. Keloid Pathophysiology and Management, viewed 14 oktober. <http://bcom.otolaryngology.com>, pp. 1-6.
Ross,EV & Anderson,RR, 1999. The Erbium Laser in Skin Resurfacing. in: Alster, TS, Apfelberg, DB (eds). Cosmetic Laser Surgery, 2nd edn. New York: Wiley-Liss, pp. 5: 73.
Shapiro,PE, 1997. Hypertropics scar and Keloid, in: Elder D (eds). Lever’s Histopathology of the Skin, 6th edn, Philadelphia-NY: Lipponcott-Ravem Publ, pp. 881 – 2.
Shetty,BS, Udupa,SL, Udupa,AL, Somayaji, SN, 2006. Effect of Centella Asiatica L (Umbelliferae) on Normal and Dexamethasone-Suppressed Wound Healing in Wistar Abino Rats. The Internasional Journal of Lower Extremity Wounds, vol.5, no 3.pp.137-43
Soo,C, Hu,FY, Zhang,X, Wang,Y, Beanes,SR, Lorenz,HP, Hedrick,MH, Mackool,RJ, Plaas,A, Kim,SJ, Longaker,MT, Freymiller,E, Ting,K, 2000. Differential expression of fibromodulin, a transforming growth factor-β modulator, in fetal skin development and scarless repair. Am J Pathol ;157: pp.423-33.
Theodora,T, 2010. Karakterisasi Simplisia, Skrining Fitokimia dan Uji Aktivitas Antioksidasi Ekstrak Etanol Kelopak Bunga Rosela (Hibicus sabdariffa L.). Fakultas Farmasi Universitas Sumatera Utara.
Tuan,TL & NichterLS, 1998. The molecular basis of keloid and hypertrophic scar faormation. Molecular Medicine,Elsevier Science ltd. pp. 19-24.
Wheeland,RG, 1996. Keloids and Hypertropic Scars. in: Ardn KA, Leboit, PE, Robinson, JK, Wintroub, BU (eds), Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, 1st edn. Philadelphia: W.B. Saunders Company, pp. 902 – 5.
Widyanto,P & Nelistya,A, 2008, in: Rosella: Aneka Olahan, Khasiat, & Ramuan, Cetakan I. Jakarta: Penebar Swadaya, pp. 1- 14.
Willem,M, Boleman, MCT, Ulrich, MMW, Molema,G, Paul,P, Middelkoop,E, Niessen,FB, 2008, Potensial Celluler and molecular causes of hypertrophic scar formation, Elsevier Ltd .<www.elsevier.com/locate/burns>.
Xia,W, Phan,TT, Lim,IJ, Longaker,MT & Yang,GP, 2004. Complex epithelial-mesenchymal interaction modulate transforming growth factor-β expression in keloid-derived cells. Wound Repair Regen ; 12: pp. 546-56.
Yamamoto,T & Nishioka, 2005. Celluler and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Experiment Dermatol ; 14: pp.81-95.
Zhang,Y, McCormick,L, & Gilliam,A, 2003. Latency associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol ; 121: pp. 713-9.
